JP4605973B2 - イヌのアレルギー治療用の組換えキメラ抗−ＩｇＥモノクローナル抗体 - Google Patents

イヌのアレルギー治療用の組換えキメラ抗−ＩｇＥモノクローナル抗体 Download PDF

Info

Publication number
JP4605973B2
JP4605973B2 JP2001557921A JP2001557921A JP4605973B2 JP 4605973 B2 JP4605973 B2 JP 4605973B2 JP 2001557921 A JP2001557921 A JP 2001557921A JP 2001557921 A JP2001557921 A JP 2001557921A JP 4605973 B2 JP4605973 B2 JP 4605973B2
Authority
JP
Japan
Prior art keywords
ige
antibody
receptor
canine
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2001557921A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003521916A (ja
JP2003521916A5 (https=
Inventor
ロバート・エル・ロートン
アショク・ピー・アイヤッパ
ウェンディ・ダブリュー・リュー
ブライオン・マーマー
ホンリアン・グオ
ユージーン・アール・クラー・ザ・サード
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Idexx Laboratories Inc
Original Assignee
Idexx Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idexx Laboratories Inc filed Critical Idexx Laboratories Inc
Publication of JP2003521916A publication Critical patent/JP2003521916A/ja
Publication of JP2003521916A5 publication Critical patent/JP2003521916A5/ja
Application granted granted Critical
Publication of JP4605973B2 publication Critical patent/JP4605973B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
JP2001557921A 2000-02-01 2001-01-30 イヌのアレルギー治療用の組換えキメラ抗−ＩｇＥモノクローナル抗体 Expired - Fee Related JP4605973B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US17962900P 2000-02-01 2000-02-01
US60/179,629 2000-02-01
US09/592,998 US6504013B1 (en) 2000-02-01 2000-06-12 Canine allergy therapeutic recombinant chimeric anti-IgE monoclonal antibody
US09/592,998 2000-06-12
PCT/US2001/002924 WO2001057090A1 (en) 2000-02-01 2001-01-30 Canine allergy therapeutic recombinant chimeric anti-ige monoclonal antibody

Publications (3)

Publication Number Publication Date
JP2003521916A JP2003521916A (ja) 2003-07-22
JP2003521916A5 JP2003521916A5 (https=) 2008-03-27
JP4605973B2 true JP4605973B2 (ja) 2011-01-05

Family

ID=26875491

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001557921A Expired - Fee Related JP4605973B2 (ja) 2000-02-01 2001-01-30 イヌのアレルギー治療用の組換えキメラ抗−ＩｇＥモノクローナル抗体

Country Status (6)

Country Link
US (1) US6504013B1 (https=)
EP (1) EP1254180B1 (https=)
JP (1) JP4605973B2 (https=)
AU (1) AU2001233102A1 (https=)
DE (1) DE60127237T2 (https=)
WO (1) WO2001057090A1 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7393529B2 (en) * 1998-04-09 2008-07-01 Idexx Laboratories, Inc. Methods and compositions for inhibiting binding of IgE to a high affinity receptor
WO2002066602A2 (en) * 2001-01-03 2002-08-29 Heska Corporation Detection of allergen-specific ige
EP1485126A4 (en) * 2001-12-21 2007-03-21 Idexx Lab Inc DOG IMMUNOGLOBULIN VARIABLE DOMAINS, DOG ANTIBODIES, AND METHOD FOR THEIR PRODUCTION AND USE
US20060034845A1 (en) 2002-11-08 2006-02-16 Karen Silence Single domain antibodies directed against tumor necrosis factor alpha and uses therefor
ES2655912T3 (es) * 2002-11-08 2018-02-22 Ablynx N.V. Anticuerpos de dominio simple dirigidos contra factor de necrosis tumoral-alfa y usos para los mismos
CA2505316C (en) * 2002-11-08 2014-08-05 Ablynx N.V. Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
US20100003253A1 (en) * 2002-11-08 2010-01-07 Ablynx N.V. Single domain antibodies directed against epidermal growth factor receptor and uses therefor
US9320792B2 (en) 2002-11-08 2016-04-26 Ablynx N.V. Pulmonary administration of immunoglobulin single variable domains and constructs thereof
GB0304576D0 (en) 2003-02-28 2003-04-02 Lonza Biologics Plc Protein a chromatography
EP1733232A1 (en) * 2004-03-23 2006-12-20 Quidel Corporation Hybrid phase lateral flow assay
US20090111702A1 (en) * 2004-04-06 2009-04-30 Mount Sinai School Of Medicine Office Of Industrial Liason Methods of determining allergen response using microarray immunoassay techniques
JP2006151880A (ja) * 2004-11-30 2006-06-15 Asahi Breweries Ltd 抗イヌＩｇＥモノクローナル抗体、その製造法および用途
AU2006223180B2 (en) 2005-03-11 2011-11-24 Wyeth Llc A method of weak partitioning chromatography
JP2007172129A (ja) * 2005-12-20 2007-07-05 Sony Corp 不揮発性メモリアクセス制御装置および不揮発性メモリ制御システム
US9388236B2 (en) 2007-07-09 2016-07-12 Nestec Sa Methods for reducing allergies caused by environmental allergens
HUE032078T2 (en) * 2007-07-09 2017-08-28 Nestec Sa Procedure for reducing allergies caused by environmental allergens
US9505829B2 (en) 2010-08-19 2016-11-29 Zoetis Belgium S.A. Anti-NGF antibodies and their use
WO2013119419A1 (en) 2012-02-08 2013-08-15 North Carolina State University Treatment of allergic diseases with recombinant antibodies
JP6199054B2 (ja) * 2013-03-19 2017-09-20 公益財団法人かずさＤｎａ研究所 抗イヌＩｇＥモノクローナル抗体並びに抗イヌＩｇＥモノクローナル抗体の重鎖可変領域及び軽鎖可変領域
JP7127859B2 (ja) 2016-11-09 2022-08-30 ノース カロライナ ステート ユニバーシティ キメラタンパク質を用いたアレルギー疾患の治療
WO2019183437A1 (en) 2018-03-23 2019-09-26 North Carolina State University Methods and compositions for antibody to high affinity receptor for ige
CN109143137B (zh) * 2018-06-14 2020-09-29 国电南瑞科技股份有限公司 一种发电机pmu装置测量精度提升方法
WO2021195560A1 (en) * 2020-03-27 2021-09-30 Aquavit Pharmaceuticals, Inc, Methods of detecting allergic reactions in subjects using microchannel delivery devices

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989006138A1 (en) 1987-12-31 1989-07-13 Tanox Biosystems, Inc. UNIQUE ANTIGENIC EPITOPES ON IgE-BEARING B LYMPHOCYTES
US5449760A (en) 1987-12-31 1995-09-12 Tanox Biosystems, Inc. Monoclonal antibodies that bind to soluble IGE but do not bind IGE on IGE expressing B lymphocytes or basophils
US5422258A (en) 1987-12-31 1995-06-06 Tanox Biosystems, Inc. Methods for producing high affinity anti-human IgE-monoclonal antibodies which binds to IgE on IgEabearing B cells but not basophils
JP2811096B2 (ja) * 1989-09-30 1998-10-15 財団法人化学及血清療法研究所 イヌ免疫グロブリンκ鎖の定常領域をコードする遺伝子断片およびマウス×イヌキメラ抗体
JP2837240B2 (ja) * 1990-06-07 1998-12-14 財団法人化学及血清療法研究所 イヌ免疫グロブリンγ鎖の定常領域をコードする遺伝子断片およびマウス×イヌキメラ抗体
JP2811089B2 (ja) * 1989-08-25 1998-10-15 財団法人化学及血清療法研究所 イヌ×マウスヘテロハイブリドーマおよびイヌ免疫グロブリンλ鎖の定常領域をコードする遺伝子断片
CA2113813C (en) * 1991-08-14 2005-04-12 Paula M. Jardieu Immunoglobulin variants for specific fc epsilon receptors
US5965709A (en) 1991-08-14 1999-10-12 Genentech, Inc. IgE antagonists
SE9102808L (sv) 1991-09-26 1993-03-27 Lars T Hellman Inst F Immunolo Vaccin, foer humant bruk, vars avsedda effekt aer att lindra symptomen eller foerhindra uppkomsten av ige-medierade allergiska reaktioner
ATE228536T1 (de) 1993-03-11 2002-12-15 Tanox Biosystems Inc Antigene epitope von ige repräsentierenden peptiden auf der b-zell-oberfläche aber nicht auf oberflächen von basophilen
US5629415A (en) 1994-11-09 1997-05-13 Merck & Co., Inc. DNA encoding canine immunoglobulin E
AU1146897A (en) 1995-12-08 1997-06-27 Idexx Laboratories, Inc. Methods and compositions concerning allergy in dogs
US5945294A (en) 1996-11-26 1999-08-31 Heska Corporation Method to detect IgE
US6060326A (en) 1997-04-07 2000-05-09 Heska Corporation Method to detect canine IgE and kit therefor
US5994511A (en) 1997-07-02 1999-11-30 Genentech, Inc. Anti-IgE antibodies and methods of improving polypeptides
ES2234180T3 (es) 1998-04-09 2005-06-16 Idexx Laboratories, Inc. Proteinas de fijacion especifica para el tratamiento de la alergia canina.
TWI227241B (en) 1998-06-20 2005-02-01 United Biomedical Inc IgE-CH3 domain antigen peptide, peptide conjugate containing the same, and pharmaceutical composition for treating allergies containing the peptide conjugate

Also Published As

Publication number Publication date
JP2003521916A (ja) 2003-07-22
AU2001233102A1 (en) 2001-08-14
DE60127237D1 (de) 2007-04-26
US6504013B1 (en) 2003-01-07
DE60127237T2 (de) 2007-12-20
EP1254180B1 (en) 2007-03-14
EP1254180A1 (en) 2002-11-06
WO2001057090A1 (en) 2001-08-09

Similar Documents

Publication Publication Date Title
JP4605973B2 (ja) イヌのアレルギー治療用の組換えキメラ抗−ＩｇＥモノクローナル抗体
WO2018170096A1 (en) Use of a cd4/cd8 bispecific antibody for the treatment of diabetes
CN1232402A (zh) 免疫调节的方法和组合物
KR102176962B1 (ko) 면역글로불린 a 수준을 증가시키기 위한 방법
JP4857396B1 (ja) 融合蛋白質
JP7678802B2 (ja) Ｓｉｇｌｅｃ－９ＥＣＤ融合分子及びその使用方法
CN107207588A (zh) 针对tau的抗体和其用途
CN1202906A (zh) Cc型趋化因子样蛋白质
JPH08500328A (ja) 突然変異したスーパー抗原の保護作用
JPH06298662A (ja) 自己免疫疾患の予防治療剤
CN116113428A (zh) 白细胞介素-2突变蛋白及其用途
US6734287B1 (en) Specific binding proteins for treating canine allergy
EP0957111B1 (en) Specific binding proteins for treating canine allergy
WO1996021028A2 (en) Soluble heterodimeric t cell receptors and their antibodies
CN1138865A (zh) 抗银屑病的多肽及方法
TW202302642A (zh) 用於治療抗體介導移植物排斥用途之抗ｃｄ３８抗體
CA2329148C (en) Specific binding proteins for treating canine allergy
EP0955311A2 (en) Peptide vaccine for canine allergy
HK40116467A (zh) 抗ox40抗体在治疗炎症或免疫性疾病中的应用
CA2329152A1 (en) Peptide vaccine for canine allergy
CN118662628A (zh) 抗ox40抗体在治疗炎症或免疫性疾病中的应用
CN116997570A (zh) 用于治疗抗体介导的移植排斥的抗cd38抗体
WO2022184068A1 (zh) 抗tigit抗体在治疗肿瘤或癌症中的应用
Schopf Molecular and immunological characterization of a Trypanosome variant surface glycoprotein
FR3064484A1 (fr) Composition d'immunoglobulines utiles pour traiter des infections virales

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080130

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080130

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100105

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100405

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100518

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100818

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100907

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20101005

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131015

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees